| Literature DB >> 20692258 |
Klaus Dittmann1, Claus Mayer, Birgit Fehrenbacher, Martin Schaller, Rainer Kehlbach, H Peter Rodemann.
Abstract
Nuclear localisation of EGFR is associated with treatment resistance of tumor cells. The aim of this study was to identify molecular targets to block nuclear shuttling of EGFR. Mutation of Thr654, located within the putative EGFR NLS demonstrated that phosphorylation of this residue is essential for nuclear EGFR shuttling following irradiation. Deletion of Thr654 blocked nuclear transport of EGFR, whereas mutation to Glu increased shuttling. Treatment with a peptide, corresponding to the phosphorylated NLS, abolished nuclear EGFR transport and reduced radiation-induced activation of DNA-PK, essential for DNA-repair. In accordance with that, lack of nuclear EGFR increased residual DNA damage in tumor cells and reduced cellular survival following irradiation. Blockage of nuclear EGFR shuttling may be a new strategy to fight treatment resistance.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20692258 DOI: 10.1016/j.febslet.2010.08.005
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124